Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$5.79M Buy
159,882
+175
+0.1% +$6.21K 1.54% 16
2020
Q4
$5.88M Sell
159,707
-4,116
-3% -$151K 1.64% 14
2020
Q3
$5.7M Buy
163,823
+7,352
+5% +$258K 1.76% 12
2020
Q2
$4.85M Buy
156,471
+11,719
+8% +$398K 1.62% 13
2020
Q1
$4.48M Buy
144,752
+431
+0.3% +$14.7K 1.86% 12
2019
Q4
$5.37M Sell
144,321
-202
-0.1% -$7.2K 1.84% 11
2019
Q3
$4.93M Sell
144,523
-97
-0.1% -$3.53K 1.82% 12
2019
Q2
$5.94M Sell
144,620
-836
-0.6% -$33.2K 2.21% 7
2019
Q1
$5.86M Sell
145,456
-161
-0.1% -$6.45K 2.18% 8
2018
Q4
$6.03M Sell
145,617
-316
-0.2% -$13.1K 2.5% 7
2018
Q3
$6.1M Buy
145,933
+379
+0.3% +$14.6K 2.16% 8
2018
Q2
$5.01M Sell
145,554
-1,009
-0.7% -$34.5K 1.91% 11
2018
Q1
$4.87M Buy
146,563
+15,596
+12% +$536K 1.97% 10
2017
Q4
$4.5M Sell
130,967
-737
-0.6% -$25.1K 1.86% 11
2017
Q3
$4.46M Sell
131,704
-645
-0.5% -$20.7K 1.93% 10
2017
Q2
$4.22M Sell
132,349
-87
-0.1% -$2.74K 1.87% 9
2017
Q1
$4.26M Sell
132,436
-287
-0.2% -$9.05K 1.88% 9
2016
Q4
$4.07M Buy
132,723
+114,460
+627% +$3.49M 1.79% 11
2016
Q3
$586K Buy
+18,263
New +$611K 0.46% 66

Other funds holding PFE

Rikoon Group's PFE Position: Q1 2021 in Review

Rikoon Group increased its Pfizer (PFE) stake by 0.11% in Q1 2021, buying an estimated $6.21K and bringing the position to 159,882 shares worth $5.79M. The position accounts for 1.54% of the portfolio, ranked #16.

Rikoon Group first reported a position in PFE in Q3 2016 and has held it in 19 quarters since. The position peaked at $6.1M in Q3 2018. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Rikoon Group held 159,882 shares of Pfizer worth $5.79M as of Q1 2021.
  • Rikoon Group bought 175 Pfizer shares in Q1 2021, an estimated $6.21K.
  • Pfizer made up 1.54% of Rikoon Group's portfolio in Q1 2021, its #16 holding.
  • Rikoon Group first reported a position in Pfizer in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's Pfizer position peaked at $6.1M in Q3 2018.
  • 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.